These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20495160)

  • 21. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
    Wilens TE; Biederman J
    J Psychopharmacol; 2006 Jul; 20(4):580-8. PubMed ID: 16174669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
    Spencer TJ; Biederman J; Mick E
    Ambul Pediatr; 2007; 7(1 Suppl):73-81. PubMed ID: 17261486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study.
    Szobot CM; Rohde LA; Bukstein O; Molina BS; Martins C; Ruaro P; Pechansky F
    Addiction; 2007 Jul; 102(7):1122-30. PubMed ID: 17567400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
    Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
    Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult ADHD and substance abuse: diagnostic and treatment issues.
    Kalbag AS; Levin FR
    Subst Use Misuse; 2005; 40(13-14):1955-81, 2043-8. PubMed ID: 16282088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
    Johann M; Bobbe G; Putzhammer A; Wodarz N
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbidity.
    Angold A; Costello EJ; Erkanli A
    J Child Psychol Psychiatry; 1999 Jan; 40(1):57-87. PubMed ID: 10102726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex.
    D'Agati E; Moavero R; Cerminara C; Curatolo P
    J Child Neurol; 2009 Oct; 24(10):1282-7. PubMed ID: 19805824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes.
    Biederman J; Makris N; Valera EM; Monuteaux MC; Goldstein JM; Buka S; Boriel DL; Bandyopadhyay S; Kennedy DN; Caviness VS; Bush G; Aleardi M; Hammerness P; Faraone SV; Seidman LJ
    Psychol Med; 2008 Jul; 38(7):1045-56. PubMed ID: 17935640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ADHD and addiction: a complicated liaison].
    Matthys F; Tremmery S; Autrique M; Joostens P; Möbius D; Stes S; Sabbe BG
    Tijdschr Psychiatr; 2012; 54(6):539-48. PubMed ID: 22753186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontiers between attention deficit hyperactivity disorder and bipolar disorder.
    Galanter CA; Leibenluft E
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):325-46, viii-ix. PubMed ID: 18295149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Goossens PJ; van Etten DM; van Achterberg T; van den Brink W
    Perspect Psychiatr Care; 2015 Jan; 51(1):4-15. PubMed ID: 24410895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse.
    Horner BR; Scheibe KE
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):30-6. PubMed ID: 9000778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited.
    Biederman J; Faraone SV; Monuteaux MC; Bober M; Cadogen E
    Biol Psychiatry; 2004 Apr; 55(7):692-700. PubMed ID: 15038997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.
    Riggs PD; Hall SK; Mikulich-Gilbertson SK; Lohman M; Kayser A
    J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):420-9. PubMed ID: 15187802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder.
    Biederman J; Monuteaux MC; Mick E; Wilens TE; Fontanella JA; Poetzl KM; Kirk T; Masse J; Faraone SV
    Biol Psychiatry; 2006 Feb; 59(3):258-64. PubMed ID: 16154546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug addiction in young prison inmates with and without attention deficit hyperactivity disorder (ADHD)].
    Retz W; Retz-Junginger P; Schneider M; Scherk H; Hengesch G; Rösler M
    Fortschr Neurol Psychiatr; 2007 May; 75(5):285-92. PubMed ID: 16586260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.